1 week Ago By ABMN Staff
TD Asset Management Inc lifted its holdings in Align Technology, Inc. ( NASDAQ:ALGN – Free Report ) by 347.1% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.
The firm owned 112,011 shares of the medical equipment provider’s stock after acquiring an additional 86,960 shares during the period. TD Asset Management Inc owned 0.15% of Align Technology worth $27,043,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in ALGN. Norges Bank purchased a new stake in shares of Align Technology in the fourth quarter worth about $223,610,000. Brown Advisory Inc.
lifted its position in shares of Align Technology by 41.4% in the fourth quarter. Brown Advisory Inc.
now owns 1,509,080 shares of the medical equipment provider’s stock worth $413,488,000 after buying an additional 441,754 shares in the last quarter. Swedbank AB purchased a new stake in shares of Align Technology in the first quarter worth about $96,117,000. Bares Capital Management Inc.
lifted its position in shares of Align Technology by 44.4% in the first quarter. Bares Capital Management Inc.
now owns 819,930 shares of the medical equipment provider’s stock worth $268,871,000 after buying an additional 252,220 shares in the last quarter. Finally, Envestnet Asset Management Inc. lifted its position in shares of Align Technology by 102.
0% in the fourth quarter. Envestnet Asset Management Inc. now owns 414,772 shares of the medical equipment provider’s stock worth $113,648,000 after buying an additional 209,419 shares in the last quarter.
88.43% of the stock is currently owned by hedge funds and other institutional investors. Align Technology Stock Down 2.
4 % Shares of NASDAQ:ALGN opened at $221.15 on Friday. Align Technology, Inc.
has a 52-week low of $176.34 and a 52-week high of $367.71.
The stock has a market cap of $16.65 billion, a P/E ratio of 36.43, a price-to-earnings-growth ratio of 5.
40 and a beta of 1.64. The business’s 50 day moving average is $233.
33 and its 200 day moving average is $269.24. Analyst Ratings Changes A number of equities research analysts recently commented on ALGN shares.
Robert W. Baird decreased their target price on Align Technology from $370.00 to $325.
00 and set an “outperform” rating on the stock in a research report on Monday, July 22nd. Morgan Stanley decreased their price objective on Align Technology from $328.00 to $310.
00 and set an “overweight” rating on the stock in a research report on Thursday, July 25th. OTR Global restated a “mixed” rating on shares of Align Technology in a research report on Tuesday, June 4th. Stifel Nicolaus decreased their price objective on Align Technology from $400.
00 to $350.00 and set a “buy” rating on the stock in a research report on Thursday, July 25th. Finally, Evercore ISI decreased their price objective on Align Technology from $370.
00 to $300.00 and set an “outperform” rating on the stock in a research report on Monday, June 10th. One analyst has rated the stock with a sell rating, four have given a hold rating and five have given a buy rating to the company’s stock.
According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $306.88.
Get Our Latest Research Report on Align Technology Insider Buying and Selling In related news, Director C Raymond Larkin, Jr. bought 6,500 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were acquired at an average price of $235.
33 per share, with a total value of $1,529,645.00. Following the transaction, the director now owns 28,247 shares of the company’s stock, valued at $6,647,366.
51. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink . 0.
62% of the stock is owned by insiders. About Align Technology ( Free Report ) Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Featured Stories Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. ( NASDAQ:ALGN – Free Report ).
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter ..
